Tp23. Tp023 Lung Transplant: Outcome Predictors and Therapeutic Options 2021
DOI: 10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a1790
|View full text |Cite
|
Sign up to set email alerts
|

Study Design of Two Phase III, Prospective, Multicenter, Randomized, Controlled Clinical Trials Evaluating the Efficacy and Safety of Liposomal Cyclosporin A for Inhalation(L-CsA-i) in Patients with Bronchiolitis Obliterans Syndrome Post Single- (BOSTON-1) or Double- (BOSTON-2) Lung Transplantation

Help me understand this report

This publication either has no citations yet, or we are still processing them

Set email alert for when this publication receives citations?

See others like this or search for similar articles